Lam Research Forecast, price target & analysts
Lam Research Target price 2026 - Analyst rating & recommendation
Lam Research Classifications & Recommendation
Lam Research Price Target
| Target Price | $387.60 |
| Price | $286.92 |
| Potential | 35.09% |
| Number of Estimates | 34 |
| 34 Analysts have issued a price target Lam Research 2027 . The average Lam Research target price is $387.60. This is 35.09% higher than the current stock price. The highest price target is $525.00 82.98% , the lowest is $215.13 25.02% . | |
| A rating was issued by 41 analysts: 35 Analysts recommend Lam Research to buy, 6 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Lam Research stock has an average upside potential 2027 of 35.09% . Most analysts recommend the Lam Research stock at Purchase. |
Sales and Margin forecast 2027, 2028 to 2031
37 Analysts have issued a sales forecast Lam Research 2027 . The average Lam Research sales estimate is
This results in the following potential growth metrics:
25 Analysts have issued an Lam Research EBITDA forecast 2027. The average Lam Research EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
37 Lam Research Analysts have issued a net profit forecast 2027. The average Lam Research net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2027, 2028 to 2031
37 Analysts have issued a Lam Research forecast for earnings per share. The average Lam Research EPS is
This results in the following potential growth metrics and future valuations:
Current Lam Research Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Morgan Stanley |
Overweight
➜
Overweight
|
Unchanged | Oct 05 2026 |
| B. Riley Securities |
Buy
➜
Buy
|
Unchanged | Oct 01 2026 |
| UBS |
Buy
➜
Buy
|
Unchanged | Sep 01 2026 |
| Mizuho |
Outperform
➜
Outperform
|
Unchanged | Aug 25 2026 |
| Morgan Stanley |
Overweight
➜
Overweight
|
Unchanged | Jul 30 2026 |
| B. Riley Securities |
Buy
➜
Buy
|
Unchanged | Jul 30 2026 |
| Jefferies |
Buy
➜
Buy
|
Unchanged | Jul 30 2026 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
|
Oct 05 2026 |
|
Unchanged
B. Riley Securities:
Buy
➜
Buy
|
Oct 01 2026 |
|
Unchanged
UBS:
Buy
➜
Buy
|
Sep 01 2026 |
|
Unchanged
Mizuho:
Outperform
➜
Outperform
|
Aug 25 2026 |
|
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
|
Jul 30 2026 |
|
Unchanged
B. Riley Securities:
Buy
➜
Buy
|
Jul 30 2026 |
|
Unchanged
Jefferies:
Buy
➜
Buy
|
Jul 30 2026 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
